1210 related articles for article (PubMed ID: 15022328)
1. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
[TBL] [Abstract][Full Text] [Related]
2. Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study.
Ainiala H; Dastidar P; Loukkola J; Lehtimäki T; Korpela M; Peltola J; Hietaharju A
Scand J Rheumatol; 2005; 34(5):376-82. PubMed ID: 16234185
[TBL] [Abstract][Full Text] [Related]
3. Fluid Attenuated Inversion Recovery (FLAIR) imaging in neuropsychiatric systemic lupus erythematosus.
Sibbitt WL; Schmidt PJ; Hart BL; Brooks WM
J Rheumatol; 2003 Sep; 30(9):1983-9. PubMed ID: 12966602
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement.
Trysberg E; Blennow K; Zachrisson O; Tarkowski A
Arthritis Res Ther; 2004; 6(6):R551-6. PubMed ID: 15535833
[TBL] [Abstract][Full Text] [Related]
6. Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings.
Kao CH; Ho YJ; Lan JL; Changlai SP; Liao KK; Chieng PU
Arthritis Rheum; 1999 Jan; 42(1):61-8. PubMed ID: 9920015
[TBL] [Abstract][Full Text] [Related]
7. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus.
Tomietto P; Annese V; D'agostini S; Venturini P; La Torre G; De Vita S; Ferraccioli GF
Arthritis Rheum; 2007 Dec; 57(8):1461-72. PubMed ID: 18050188
[TBL] [Abstract][Full Text] [Related]
8. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychiatric systemic lupus erythematosus: diagnostic and clinical features according to revised ACR criteria.
Buća A; Perković D; Martinović-Kaliterna D; Vlastelica M; Titlić M
Coll Antropol; 2009 Mar; 33(1):281-8. PubMed ID: 19408638
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-9 promoter polymorphisms in Korean patients with systemic lupus erythematosus.
Lee YJ; Woo M; Nam JH; Baek J; Im CH; Lee EY; Lee EB; Park KS; Song YW
Hum Immunol; 2008 Jun; 69(6):374-9. PubMed ID: 18571010
[TBL] [Abstract][Full Text] [Related]
11. Evidence of central nervous system damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging.
Bosma GP; Rood MJ; Zwinderman AH; Huizinga TW; van Buchem MA
Arthritis Rheum; 2000 Jan; 43(1):48-54. PubMed ID: 10643699
[TBL] [Abstract][Full Text] [Related]
12. Cognitive and neurologic status in patients with systemic lupus erythematosus without major neuropsychiatric syndromes.
Kozora E; Arciniegas DB; Filley CM; West SG; Brown M; Miller D; Grimm A; Devore MD; Wingrove C; Zhang L
Arthritis Rheum; 2008 Nov; 59(11):1639-46. PubMed ID: 18975359
[TBL] [Abstract][Full Text] [Related]
13. Cerebral and corpus callosum atrophy in systemic lupus erythematosus.
Appenzeller S; Rondina JM; Li LM; Costallat LT; Cendes F
Arthritis Rheum; 2005 Sep; 52(9):2783-9. PubMed ID: 16142703
[TBL] [Abstract][Full Text] [Related]
14. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
Yoshio T; Hirata D; Onda K; Nara H; Minota S
J Rheumatol; 2005 Jan; 32(1):34-9. PubMed ID: 15630721
[TBL] [Abstract][Full Text] [Related]
15. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.
Mikdashi J; Handwerger B
Rheumatology (Oxford); 2004 Dec; 43(12):1555-60. PubMed ID: 15342927
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease.
Kozora E; West SG; Kotzin BL; Julian L; Porter S; Bigler E
Arthritis Rheum; 1998 Jan; 41(1):41-7. PubMed ID: 9433868
[TBL] [Abstract][Full Text] [Related]
17. Valvular heart disease is associated with nonfocal neuropsychiatric systemic lupus erythematosus.
Roldan CA; Gelgand EA; Qualls CR; Sibbitt WL
J Clin Rheumatol; 2006 Feb; 12(1):3-10. PubMed ID: 16484873
[TBL] [Abstract][Full Text] [Related]
18. Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosus.
Ikenouchi-Sugita A; Yoshimura R; Okamoto T; Umene-Nakano W; Ueda N; Hori H; Katsuki A; Saito K; Tanaka Y; Nakamura J
World J Biol Psychiatry; 2010 Mar; 11(2):121-8. PubMed ID: 20109107
[TBL] [Abstract][Full Text] [Related]
19. Correlation of magnetization transfer ratio histogram parameters with neuropsychiatric systemic lupus erythematosus criteria and proton magnetic resonance spectroscopy: association of magnetization transfer ratio peak height with neuronal and cognitive dysfunction.
Emmer BJ; Steup-Beekman GM; Steens SC; Huizinga TW; van Buchem MA; van der Grond J
Arthritis Rheum; 2008 May; 58(5):1451-7. PubMed ID: 18438847
[TBL] [Abstract][Full Text] [Related]
20. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]